[
  {
    "ts": null,
    "headline": "Boston Scientific Corp (BSX) Q3 2025 Earnings Call Highlights: Strong Sales Growth and ...",
    "summary": "Boston Scientific Corp (BSX) reports robust operational and organic sales growth, driven by key segments and strategic expansions, despite regional challenges.",
    "url": "https://finnhub.io/api/news?id=998e6497faef58e7fbdd2debdc6d9f11e53b29d760e147a3c6850639b04f262b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761159672,
      "headline": "Boston Scientific Corp (BSX) Q3 2025 Earnings Call Highlights: Strong Sales Growth and ...",
      "id": 137192030,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corp (BSX) reports robust operational and organic sales growth, driven by key segments and strategic expansions, despite regional challenges.",
      "url": "https://finnhub.io/api/news?id=998e6497faef58e7fbdd2debdc6d9f11e53b29d760e147a3c6850639b04f262b"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific lifts FY25 outlook amid continued cardiovascular boom",
    "summary": "Boston achieved a 22.4% growth in its cardiovascular business in Q3, continuing the segment’s growth trend in 2025 due to the ongoing adoption of its Farapulse PFA system.",
    "url": "https://finnhub.io/api/news?id=073682005cedc6c65fc781dcedcab2a33c19b8a92286e1700fdc114edf685001",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761155066,
      "headline": "Boston Scientific lifts FY25 outlook amid continued cardiovascular boom",
      "id": 137188251,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston achieved a 22.4% growth in its cardiovascular business in Q3, continuing the segment’s growth trend in 2025 due to the ongoing adoption of its Farapulse PFA system.",
      "url": "https://finnhub.io/api/news?id=073682005cedc6c65fc781dcedcab2a33c19b8a92286e1700fdc114edf685001"
    }
  },
  {
    "ts": null,
    "headline": "GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring",
    "summary": "GE HealthCare secures CE mark for Carevance, advancing scalable, cost-effective monitoring across care settings.",
    "url": "https://finnhub.io/api/news?id=cdd174d5f51737522662514202aa4cea588b0c443ac81d17ec1fc739f0d4bf22",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761153900,
      "headline": "GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring",
      "id": 137192031,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "GE HealthCare secures CE mark for Carevance, advancing scalable, cost-effective monitoring across care settings.",
      "url": "https://finnhub.io/api/news?id=cdd174d5f51737522662514202aa4cea588b0c443ac81d17ec1fc739f0d4bf22"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=843856a5f4a2112928fb5b4b57a7e7a6712bcdd49e52f3facf4ceeab33d081d3",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761150960,
      "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "id": 137252043,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=843856a5f4a2112928fb5b4b57a7e7a6712bcdd49e52f3facf4ceeab33d081d3"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Makes A Bullish Move After Sales In One Segment Skyrocket 63%",
    "summary": "Boston Scientific Makes A Bullish Move After Sales In One Segment Skyrocket 63%",
    "url": "https://finnhub.io/api/news?id=3f99629c3c78cb28ac9ec6e6947d6b53333dd7168d0bdad2923c1290fe7492b7",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761149247,
      "headline": "Boston Scientific Makes A Bullish Move After Sales In One Segment Skyrocket 63%",
      "id": 137252019,
      "image": "",
      "related": "BSX",
      "source": "DowJones",
      "summary": "Boston Scientific Makes A Bullish Move After Sales In One Segment Skyrocket 63%",
      "url": "https://finnhub.io/api/news?id=3f99629c3c78cb28ac9ec6e6947d6b53333dd7168d0bdad2923c1290fe7492b7"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Stock Is Up, What You Need To Know",
    "summary": "Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.4% in the morning session after the company reported strong third-quarter results that topped Wall Street's forecasts and raised its full-year financial outlook.",
    "url": "https://finnhub.io/api/news?id=5c72a298acadf2e84cbfe99c8e6694a0e9c029641dd642849a7aaa2dcfe7e579",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761148299,
      "headline": "Boston Scientific (BSX) Stock Is Up, What You Need To Know",
      "id": 137188252,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.4% in the morning session after the company reported strong third-quarter results that topped Wall Street's forecasts and raised its full-year financial outlook.",
      "url": "https://finnhub.io/api/news?id=5c72a298acadf2e84cbfe99c8e6694a0e9c029641dd642849a7aaa2dcfe7e579"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corporation (BSX) Q3 2025 Earnings Call Transcript",
    "summary": "Boston Scientific Corporation (NYSE:BSX) Q3 2025 Earnings Call October 22, 2025 8:00 AM EDTCompany ParticipantsLauren Tengler - Director of Investor...",
    "url": "https://finnhub.io/api/news?id=19ec0121162f6844d0d339b0459cf2634dda442b52775f5efae33084cdeda5bd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761144828,
      "headline": "Boston Scientific Corporation (BSX) Q3 2025 Earnings Call Transcript",
      "id": 137190100,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Boston Scientific Corporation (NYSE:BSX) Q3 2025 Earnings Call October 22, 2025 8:00 AM EDTCompany ParticipantsLauren Tengler - Director of Investor...",
      "url": "https://finnhub.io/api/news?id=19ec0121162f6844d0d339b0459cf2634dda442b52775f5efae33084cdeda5bd"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Lifts Full-Year Outlook as Third-Quarter Results Top Views",
    "summary": "Boston Scientific (BSX) raised its full-year guidance on Wednesday as the medical device supplier's",
    "url": "https://finnhub.io/api/news?id=8e365458b9cfe443da777324ae449ce0fc342fd940a6868ffcca9e51205fdcad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761143154,
      "headline": "Boston Scientific Lifts Full-Year Outlook as Third-Quarter Results Top Views",
      "id": 137188254,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) raised its full-year guidance on Wednesday as the medical device supplier's",
      "url": "https://finnhub.io/api/news?id=8e365458b9cfe443da777324ae449ce0fc342fd940a6868ffcca9e51205fdcad"
    }
  },
  {
    "ts": null,
    "headline": "Update: Boston Scientific Shares Rise After Q3 Results Top Estimates, 2025 Outlook Lifted",
    "summary": "(Updates with latest stock movement in the headline and first paragraph.) Boston Scientific (BSX)",
    "url": "https://finnhub.io/api/news?id=f450158c89895e1c192057776e1d730b0990b87e59330cb86a319595ff8510e8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761141124,
      "headline": "Update: Boston Scientific Shares Rise After Q3 Results Top Estimates, 2025 Outlook Lifted",
      "id": 137188255,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "(Updates with latest stock movement in the headline and first paragraph.) Boston Scientific (BSX)",
      "url": "https://finnhub.io/api/news?id=f450158c89895e1c192057776e1d730b0990b87e59330cb86a319595ff8510e8"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates",
    "summary": "Although the revenue and EPS for Boston Scientific (BSX) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finnhub.io/api/news?id=60ee67a3fc37ac847152a3048f97571b0bc064d372fd657155fdbabc48dc44aa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761139803,
      "headline": "Boston Scientific (BSX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates",
      "id": 137188256,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Although the revenue and EPS for Boston Scientific (BSX) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
      "url": "https://finnhub.io/api/news?id=60ee67a3fc37ac847152a3048f97571b0bc064d372fd657155fdbabc48dc44aa"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Beats on Q3 Earnings, Raises 2025 View, Stock Up",
    "summary": "BSX posts strong Q3 with 19% EPS growth, lifts 2025 sales and EPS outlook as shares edge higher.",
    "url": "https://finnhub.io/api/news?id=5cf06891b2146944038954be6e2011361d9e9834682e74f4e1ec5dca2c184079",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761139380,
      "headline": "Boston Scientific Beats on Q3 Earnings, Raises 2025 View, Stock Up",
      "id": 137188257,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BSX posts strong Q3 with 19% EPS growth, lifts 2025 sales and EPS outlook as shares edge higher.",
      "url": "https://finnhub.io/api/news?id=5cf06891b2146944038954be6e2011361d9e9834682e74f4e1ec5dca2c184079"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific continues to win in electrophysiology",
    "summary": "Strong sales growth in the company’s electrophysiology unit comes amid a market fight between some of the medtech industry’s largest players.",
    "url": "https://finnhub.io/api/news?id=3df2b3ea5b20fe61734d1e379d0b911807722a52ca470204ff067959cd4b02b6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761134700,
      "headline": "Boston Scientific continues to win in electrophysiology",
      "id": 137188258,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Strong sales growth in the company’s electrophysiology unit comes amid a market fight between some of the medtech industry’s largest players.",
      "url": "https://finnhub.io/api/news?id=3df2b3ea5b20fe61734d1e379d0b911807722a52ca470204ff067959cd4b02b6"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Q3 Earnings and Revenues Top Estimates",
    "summary": "Boston Scientific (BSX) delivered earnings and revenue surprises of +5.63% and +1.94%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=89ecbd730b684cf47d4860fcb879f8d6e4b5996c07fa0353f77e8a59f54637ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761133501,
      "headline": "Boston Scientific (BSX) Q3 Earnings and Revenues Top Estimates",
      "id": 137188259,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) delivered earnings and revenue surprises of +5.63% and +1.94%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=89ecbd730b684cf47d4860fcb879f8d6e4b5996c07fa0353f77e8a59f54637ee"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Down Pre-Bell as Trump Signals Xi Jinping Meeting May Not Happen; Tesla Earnings on Deck",
    "summary": "The main US stock measures were trending lower in Wednesday's premarket activity as President Donald",
    "url": "https://finnhub.io/api/news?id=1c5e5e9545fda3f7d26d32204b7c7a0942466615cab54449df9e60010fc7ea0b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761133015,
      "headline": "Stocks Down Pre-Bell as Trump Signals Xi Jinping Meeting May Not Happen; Tesla Earnings on Deck",
      "id": 137187920,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The main US stock measures were trending lower in Wednesday's premarket activity as President Donald",
      "url": "https://finnhub.io/api/news?id=1c5e5e9545fda3f7d26d32204b7c7a0942466615cab54449df9e60010fc7ea0b"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific’s (NYSE:BSX) Q3 Sales Top Estimates",
    "summary": "Medical device company Boston Scientific (NYSE:BSX) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 20.3% year on year to $5.07 billion. Guidance for next quarter’s revenue was better than expected at $5.27 billion at the midpoint, 1.7% above analysts’ estimates. Its non-GAAP profit of $0.75 per share was 5.1% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=bb577a53829c684b159f2f9e0d8bbe9261c2966b3362895718f437dd21c29c16",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761130866,
      "headline": "Boston Scientific’s (NYSE:BSX) Q3 Sales Top Estimates",
      "id": 137188261,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Medical device company Boston Scientific (NYSE:BSX) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 20.3% year on year to $5.07 billion. Guidance for next quarter’s revenue was better than expected at $5.27 billion at the midpoint, 1.7% above analysts’ estimates. Its non-GAAP profit of $0.75 per share was 5.1% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=bb577a53829c684b159f2f9e0d8bbe9261c2966b3362895718f437dd21c29c16"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Raises Outlook on Continued Cardiovascular Growth",
    "summary": "The medical device company recorded higher third-quarter sales and raised its full-year earnings guidance on the back of continued growth in its cardiovascular segment.",
    "url": "https://finnhub.io/api/news?id=434ab248135d515122403609573efb7d2fb5f3d76f9df621202da133ece616a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761130740,
      "headline": "Boston Scientific Raises Outlook on Continued Cardiovascular Growth",
      "id": 137188262,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The medical device company recorded higher third-quarter sales and raised its full-year earnings guidance on the back of continued growth in its cardiovascular segment.",
      "url": "https://finnhub.io/api/news?id=434ab248135d515122403609573efb7d2fb5f3d76f9df621202da133ece616a8"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific: Q3 Earnings Snapshot",
    "summary": "The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of 71 cents per share. The medical device manufacturer posted revenue of $5.07 billion in the period, which also beat Street forecasts.",
    "url": "https://finnhub.io/api/news?id=be5ef22cb1a7728db034469baba15c049a16377f01a790db8d5f82b666331b1e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761129618,
      "headline": "Boston Scientific: Q3 Earnings Snapshot",
      "id": 137188263,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of 71 cents per share. The medical device manufacturer posted revenue of $5.07 billion in the period, which also beat Street forecasts.",
      "url": "https://finnhub.io/api/news?id=be5ef22cb1a7728db034469baba15c049a16377f01a790db8d5f82b666331b1e"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific announces results for third quarter 2025",
    "summary": "Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a reported basis, 19.4 percent on an operational1 basis and 15.3 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $755 million or $0.51 per share (EPS), compared to $469 million or $0.32 per share a year ago, and achieved adjusted3 EPS of $0.75 for",
    "url": "https://finnhub.io/api/news?id=d60584d1e61f014b18d9c6b1eb3449e99728992b800fd69f5a903a32ba5666bd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761129000,
      "headline": "Boston Scientific announces results for third quarter 2025",
      "id": 137188264,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a reported basis, 19.4 percent on an operational1 basis and 15.3 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $755 million or $0.51 per share (EPS), compared to $469 million or $0.32 per share a year ago, and achieved adjusted3 EPS of $0.75 for",
      "url": "https://finnhub.io/api/news?id=d60584d1e61f014b18d9c6b1eb3449e99728992b800fd69f5a903a32ba5666bd"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corporation 2025 Q3 - Results - Earnings Call Presentation",
    "summary": "2025-10-22. The following slide deck was published by Boston Scientific Corporation in conjunction with their 2025 Q3 earnings call.",
    "url": "https://finnhub.io/api/news?id=5a338fc9f6c4b0a61e9e1902958fd00a4bab18e750b98f2f6ab50ddb27372058",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761122950,
      "headline": "Boston Scientific Corporation 2025 Q3 - Results - Earnings Call Presentation",
      "id": 137186597,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "2025-10-22. The following slide deck was published by Boston Scientific Corporation in conjunction with their 2025 Q3 earnings call.",
      "url": "https://finnhub.io/api/news?id=5a338fc9f6c4b0a61e9e1902958fd00a4bab18e750b98f2f6ab50ddb27372058"
    }
  },
  {
    "ts": null,
    "headline": "Tesla Earnings, Inflation Data: What to Watch Over the Rest of This Week",
    "summary": "The U.S. government shutdown continues, but investors won't be completely starved for economic data. Friday brings a delayed look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.",
    "url": "https://finnhub.io/api/news?id=b36893e8e700a944d1c7e700623178661584b7bc6424c913e9ac2c818049b398",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761118582,
      "headline": "Tesla Earnings, Inflation Data: What to Watch Over the Rest of This Week",
      "id": 137187923,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The U.S. government shutdown continues, but investors won't be completely starved for economic data. Friday brings a delayed look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.",
      "url": "https://finnhub.io/api/news?id=b36893e8e700a944d1c7e700623178661584b7bc6424c913e9ac2c818049b398"
    }
  },
  {
    "ts": null,
    "headline": "Tesla headlines Wednesday's earnings slate",
    "summary": "Tesla headlines Wednesday's earnings slate",
    "url": "https://finnhub.io/api/news?id=6e988bf5a9d7799b6a8d63a25f4ea3c8ea1f01b54119a37a800668d7e27715d4",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761109335,
      "headline": "Tesla headlines Wednesday's earnings slate",
      "id": 137225950,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Tesla headlines Wednesday's earnings slate",
      "url": "https://finnhub.io/api/news?id=6e988bf5a9d7799b6a8d63a25f4ea3c8ea1f01b54119a37a800668d7e27715d4"
    }
  }
]